News & Commentary

I wanted to pass along an op-ed that I wrote for USA Today.  The piece, which was published this week, focuses on how rural health care would suffer if the Affordable Care Act is repealed.  In particular, I write about how the ACA … [Read more...]

Clearing Off The Desk...... In my latest column, I am going to tackle a few issues that are timely and relevant to 340B stakeholders. Sometimes, I will take a deep dive into a particular subject, but there is so much going on right now with 340B, … [Read more...]

For the last two years, the 340B program has come under unprecedented scrutiny from the Trump Administration and Congress. In the prior congressional session, several studies were conducted by federal and congressional watchdogs, five hearings were … [Read more...]

Will prescription drugs get cheaper this year? An expert rates the odds. This article first appeared in USA Today on January 7, 2019 Ted Slafsky, Opinion contributor As a 25-year veteran of the drug-pricing battle on Capitol Hill, I’m … [Read more...]

Ted Slafsky, who served as President/CEO of 340B Health, has launched Wexford Solutions. Wexford provides services in three key areas: Government relations, business development and communications. Mr. Slafsky has tremendous access to Congress, the … [Read more...]

To say it has been a challenging two years for providers participating in the 340B drug discount program would be an understatement. This once-obscure federal program, which was enacted by Congress on an almost unanimous vote 26 years ago, has become … [Read more...]

October 22, 2018 Dear Friends and Colleagues, I am very excited to announce that I have launched a consulting firm—Wexford Solutions.  First you might ask, why Wexford?  I happen to live on Wexford Drive so the company reminds me of home--a … [Read more...]

The debate over the future of the 340B drug pricing program has reached a critical new phase. Several members of Congress introduced legislation that would make dramatic changes in the 26-year-old statute, Congress is holding hearings on the program … [Read more...]

We recently celebrated the 25th anniversary of the 340B Drug Pricing Program, signed into law by then-President George H.W. Bush. With strong bipartisan support, the law requires drug companies to discount their prices when they sell to clinics, … [Read more...]

Why would a group that claims to hate government waste want to tear down a small federal health-care program that saves taxpayers money? We should first start by following the money. In The Hill, the group Citizens Against Government Waste tore … [Read more...]